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SHORT COMMUNICATION
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Summary Human papillomavirus DNA was detected in cervical specimens from 366 sexually active young
women with cytomorphologically normal cervices using the polymerase chain reaction. In 93% (25/27) of
initially infected women, the same viral type was not detected upon re-examination four menstrual cycles later.
These results suggest that the majority of HPV infections in young women are transient.
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During the last decade considerable evidence has accumul-
ated indicating a central role for human papillomaviruses
(HPVs) in the aetiology of cervical cancer (zur Hausen, 1991;
Schiffman, 1992). Current knowledge regarding the natural
history of HPV infection is limited. Cross-sectional studies
have shown that cervical HPV infection is common among
women with normal cervicovaginal cytology; point pre-
valence measurements in such women were seen to peak in
sexually active teenagers and women in their early twenties
and then to decrease substantially with increasing age (Ley et
al., 1991; Melkert et al., 1993; Morrison et al., 1991). This
early peak in the prevalence of detectable HPV DNA in
cytologically normal women contrasts with the peak pre-
valence of high-grade cervical intraepithelial neoplasia (CIN)
occurring 5-10 years later and the plateau of invasive cancer
observed 20 years subsequently. On the basis of these cross-
sectional data it was speculated that infection with HPV
frequently occurs within a few years of the onset of sexual
activity, running a transient self-limiting course in the
majority ofinfected women and a chronic or recurrent course
in a minority who may ultimately develop cervical neoplasia
(Schiffman, 1992; Morrison, 1994).
Very few longitudinal studies have investigated the natural
history of infection by repeated type-specific testing for HPV.
In a study of 51 sexually experienced teenagers screened on
two separate occasions a median of 13 months apart, 20 and
13 women had HPV detectable by southern blot hybridisa-
tion at the first and second visits respectively. Four women
were HPV positive on both occasions, however only one
patient had infection with the same HPV type (Rosenfeld et
al., 1992). While acknowledging that transient infection was
one possible explanation for these findings, the authors were
unable to exclude the possibility that HPV infection in some
women may remain in a latent state or be present at a level
undetectable by the Southern blot technique. Preliminary
data from cohort studies of young women using the more
sensitive polymerase chain reaction (PCR) do, however, sup-
port the hypothesis that most HPV infections in such women
are transient and clinically unimportant (Moscicki et al.,
1993; Schneider et al., 1992). We present evidence from a
large longitudinal study of healthy, sexually active women
which corroborates the transience of the majority of cervical
HPV infections.
Patients and methods
Studypopulation
A total of 366 women were studied as part of a multicentre,
multicountry (Sweden, Finland, Holland) European phase III
clinical trial for a novel contraceptive device [Silastic vaginal
multicompartment ring, releasing 3-ketodesogestrel (0.120 mg
daily) and ethinyloestradiol (0.015 mg daily) (NV Organon,
Oss, The Netherlands)]. These women were healthy, sexually
active, not pregnant and aged between 18 and 35 years (mean
28 years, s.d. 3.55 years). All agreed to participate without
changing their sexual behaviour. The majority were married
or in a long-standing relationship. All women had a history
of regular cervical smears, none of which had demonstrated
any abnormality of cytomorphology. Informed consent for
this study was obtained in all cases.
Specimen collection
Combined cytobrush-spatula sampling of the cervix was per-
formed on two occasions, before (cycle 0) and four menstrual
cycles after (cycle 4), device insertion. On each occasion a
Papanicolaou smear was sent for standard cytological assess-
ment and HPV detection was performed using the
polymerase chain reaction. Smears were assessed by one of
the authors (MEB), without knowledge of the results of HPV
PCR.
Detection ofHPV DNA
Detection of HPV DNA was performed directly on cells
suspended in Kryofix (Merck, product no. 5201) using a
combination of general primer-mediated and type-specific
PCR (GP/TS-PCR) (Walboomers et al., 1992). This com-
bination of PCR techniques allows the rapid, sensitive and
reliable detection of a broad spectrum of HPV genotypes in
cervical cell suspensions (van den Brule et al., 1990). GP/TS-
PCR facilitates the testing of large groups of smears and is
considered the technique ofchoice for epidemiological studies
(Schiffman, 1992).
Initially, PCR was performed using general HPV primers
GP 5/6 to determine the overall presence of HPV. This
screening detects presently unsequenced genital HPV types,
at the subpicogram level, in addition to the sequenced genital
HPV types 6, 11, 16, 18, 31 and 33 (Snijders et al., 1990).
Following low-stringency Southern blot analysis with probes
of HPV-specific PCR products, cases positive with general
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primer-mediated PCR underwent type-specific PCR to deter-
mine the specific HPV type(s) present. The specific primers
used are detailed elsewhere (Walboomers et al., 1992).
Reaction products were identified using standard gel elec-
trophoresis. Confirmation of HPV positivity was carried out
randomly and repeatedly on one out of every three gels, by
Southern blotting using internal olignucleotide probes.
Cases in which general primer PCR was positive but type-
specific PCR was negative were considered to contain pres-
ently unidentified HPV genotypes.
In every case PCR using P-globin gene-specific primers was
successfully performed, indicating the presence of amplifiable
DNA. All PCR reactions were carried out in duplicate and in
cases of discrepancy analysis was repeated. In order to
minimise false-positive PCR reactions, specific precautions
were taken as detailed elsewhere (van den Brule et al., 1990).
Results
Cervicovaginal cytology of all women on both occasions was
normal and did not show koilocytic change suggestive of
HPV infection. In 10.9% (40/366) of women HPV positivity
was detected by PCR on one or both occasions, 7.38%
(27/366) at cycle 0 and 6.83% (25/366) at cycle 4 (Table I)
(P>0.10, chi-squared test). Presence of the vaginal device
thus appears not to have affected HPV detection. HPV DNA
was detected in the same woman on both occasions in 3.28%
(12/366), however persistence of the same viral type occurred
in only two of these cases (0.55%) (Table I, cases 31 and 40).
Discussion
In this study of healthy, sexually active young women the
overall HPV point prevalence was 7.11% with HPV 16/18
accounting for 23% of the total. These results are similar to
those found by Melkert et al. (1993), who used the same
GP/TS-PCR technique in a comprehensive cross-sectional
study of women with cytomorphologically normal cervical
smears.
The main finding of the present study was that cervical
HPV infection was transient in the majority of infected
women: in 10/12 women who were positive on both
occasions, different viral types were identified. Indeed, it is
possible that the two cases with the same viral type on both
occasions may represent reinfection of a cleared infection, as
others have documented changes in HPV status from positive
to negative to positive again in as little as 10 weeks
(Schneider et al., 1992).
To date, the hypothesis that the majority of HPV infec-
tions in cytologically normal women are transient has only
been directly supported by limited studies of sexually active
teenagers at high risk for the development of cervical neo-
plasia (Moscicki et al., 1993), and also in young women, in
whom the incidence of CIN was ten times higher than
generally reported and who were thus considered non-
representative of the general population (Schneider et al.,
1992). In their study of 21 young women screened every 5
weeks for 1 year, Schneider et al. (1992) found that, although
a total of 14 women were HPV 16 PCR positive on at least
one occasion, viral DNA was detected continuously in only
two women. Similarly, although almost 50% of a goup of 27
teenagers had more than one positive PCR test when fol-
lowed over a 2 year period, in 'the majority' of these women
the infections were intermittent as opposed to continuous
(Moscicki et a!., 1993). These data are thus similar to our
Table I Positive results of PCR for HPV
Case(s) Cycle 0 Cycle 4
1-4 X
5 6
6 11
7-11 31
12 33
13-21 X -
22-24 X X
25 X 18
26 6 -
27 11 31
28 16 -
29 18 -
30 18 16
31 18 18
32 31 -
33 31 6
34 _ 18,31
35 X 11,31
36 X 16,31
37 6,18 16
38,39 6,31 -
40 11,16 11
HPV DNA positive for a particular subtype is indicated where
appropriate. X, HPV DNA positive with general primer only. -,
HPV DNA negative.
own findings that in 93% (25/27) of initially infected women
the same viral type could not be detected four cycles later.
The need for prospective studies was stressed recently, to
assess whether the high prevalence of HPV in young women
represents the natural (predominantly transient) course of
infection occurring after the onset of sexual activity or
whether this heralds an epidemic ofcervical neoplasia, result-
ing from a cohort effect of increasing HPV infection in such
women (Schiffman, 1992; Morrison, 1994). Such a cohort
effect cannot be completely excluded, as there is some
evidence that the incidence of CIN in young women is in-
creasing (Elliot et al., 1989). However, our data strongly
support the former explanation for the decreasing age trend
in HPV prevalence and corroborate the hypothesis that the
majority of HPV infections are transient in a cohort of
women more representative of the general population than
those previously studied.
The potential benefits of HPV DNA detection by PCR as
an adjunct to current cervical cytological screening program-
mes continue to be debated (Koss, 1993; Frable, 1994). A
recent study suggested that HPV typing and quantitation by
PCR might usefully augment cytology by helping to decide
which women with a mild abnormality on smear need
immediate referral for colposcopy (Cuzick et al., 1994). With
regard to the broader issue of HPV testing in routine screen-
ing, as HPV infection of healthy, sexually active young
women appears to be transient in the vast majority of cases,
we concur with others that single point measurements of
HPV by PCR are of limited value for assessment of an
individual's HPV status (Schneider et al., 1992), at least in
women under 35 years of age. HPV population screening
might, however, have prognostic relevance if an age limit
could be established above which most infections are likely to
be non-transient and associated with a risk of subsequently
developing neoplasia.
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